Does METHYLPREDNISOLONE Cause Malignant neoplasm progression? 158 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 158 reports of Malignant neoplasm progression have been filed in association with METHYLPREDNISOLONE (Medroloan II SUIK). This represents 0.3% of all adverse event reports for METHYLPREDNISOLONE.
158
Reports of Malignant neoplasm progression with METHYLPREDNISOLONE
0.3%
of all METHYLPREDNISOLONE reports
66
Deaths
53
Hospitalizations
How Dangerous Is Malignant neoplasm progression From METHYLPREDNISOLONE?
Of the 158 reports, 66 (41.8%) resulted in death, 53 (33.5%) required hospitalization, and 12 (7.6%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for METHYLPREDNISOLONE. However, 158 reports have been filed with the FAERS database.
What Other Side Effects Does METHYLPREDNISOLONE Cause?
Off label use (10,364)
Drug ineffective (9,959)
Product use in unapproved indication (4,115)
Condition aggravated (3,784)
Headache (3,419)
Fatigue (3,250)
Pyrexia (3,226)
Pain (3,165)
Nausea (3,105)
Pneumonia (3,006)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which METHYLPREDNISOLONE Alternatives Have Lower Malignant neoplasm progression Risk?
METHYLPREDNISOLONE vs METHYLPREDNISOLONE ACEPONATE
METHYLPREDNISOLONE vs METHYLPREDNISOLONE HEMISUCCINATE
METHYLPREDNISOLONE vs METILDIGOXIN
METHYLPREDNISOLONE vs METOCLOPRAMIDE
METHYLPREDNISOLONE vs METOLAZONE